STEMCELL Technologies Canada Inc.

6 enregistrements totalisant 81,675,846.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Registre des lobbyistes — correspondance possible correspondance par nom

Une organisation portant ce nom figure dans 43 enregistrements de lobbying fédéral (2 actuellement actifs), entre 2016 et 2026.

932944-360439-23 922144-359572-20 — Keith Serry Counsel 932944-360439-22

Correspondance automatique par nom d'organisation; une autre organisation du même nom est possible. Le Registre des lobbyistes fait foi. Le lobbying est légal et encadré — ceci est du contexte, pas une allégation.

Par ministère

Enregistrements

Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
SIF Stream2- Growth
EF 2024-2025
Canada

These two biomanufacturing Good Manufacturing Practices (GMP) facilities will be established to enable the production of essential Messenger Ribonucleic Acid (mRNA) vaccines, viral diagnostics and ant...

Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
SIF Stream3- Attraction
EF 2017-2018
Canada

The project involves designing, building and operating a multiproduct Advanced Biologics Manufacturing Facility capable of manufacturing products such as cell culture media, cell separation products a...

Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada
Regional Economic Growth through Innovation
EF 2019-2020
Canada

Improve quality management system & upgrade cell separation products for new markets

Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
Life Sciences Fund Contributions
EF 2025-2026
Canada

STEMCELL Technologies will manufacture a proprietary medium developed for mammalian cell culture and protein expression used in the vaccine manufacturing process.

Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada
Western Diversification Program
EF 2014-2015
Canada

To develop tools and assays for 3D cell culture

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada

To accelerate the screening and validation of therapeutic drugs to treat COVID-19, Project Exhale will develop two critical new media products and associated protocols to culture human alveolar cells...